Abbott Honored With Scrip Award for Leadership in Corporate Social Responsibility
Award Recognizes Long-Term Results of Partnership to Strengthen Tanzania's Health Care System
Scrip honored Abbott and its philanthropic foundation, the Abbott Fund, with a 2011 Scrip Award for Corporate Social Responsibility (CSR) at Scrip's seventh annual awards ceremony in London. The award was presented in recognition of the significant results achieved through a decade-long, public-private partnership with the Government of Tanzania to modernize the country's health system and address critical needs in the fight against HIV/AIDS and other life-long diseases.
"We're proud to receive this Scrip CSR Award on behalf of our Abbott Fund colleagues and the Government of Tanzania," said John B. Thomas, President, Abbott Fund. "Over the past decade, we've combined our collective expertise and resources to fundamentally and sustainably upgrade the country's health care system. This collaborative approach has supported nationwide improvements in addressing lifelong diseases, while also strengthening broader health care services provided to all Tanzanians."
A key component of the programme is the involvement of highly specialised Abbott employee volunteers. This includes lab technicians who have provided extensive training and mentoring for lab staff in Tanzania, as well as contributions from other experts working in construction, engineering, facility and equipment maintenance, health care management, information technology, security and waste management. To date, Abbott employees have contributed more than 10,000 hours of on-the-ground support for the initiative. In addition, Abbott and the Abbott Fund have invested more than pounds Sterling 55 million (U.S. $90 million) in the Tanzania programme.
Most read news
Other news from the department business & finance

Get the life science industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.
More news from our other portals
Last viewed contents
Spanish biotechnology should focus on food and plant sectors to be more competitive

Risk of serious COVID-19 infection can now be predicted - Researchers develop rapid test for severe infections
First Human Dosing of Gerilimzumab - RuiYi initiates clinical trial for autoimmune disorders drug
Sartorius Reviews Fiscal 2013 Results
Novel gene drives development of different types of ovarian cancer
